Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

Journal of the National Cancer Institute

Volumn 93, Issue 11, 2001, Pages 824-842

  Howe, Holly L ^a   Wingo, Phyllis A ^b   Thun, Michael J ^c   Ries, Lynn A G ^d   Rosenberg, Harry M ^e   Feigal, Ellen G ^d   Edwards, Brenda K ^d  

^a North American Association of Central Cancer Registries   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; EARLY DIAGNOSIS; ESOPHAGUS CANCER; FEMALE; GENDER; HEALTH CARE MANAGEMENT; HEALTH STATISTICS; HEALTH STATUS; HEART CANCER; HUMAN; INTESTINE CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MODEL; NONHODGKIN LYMPHOMA; NORTH AMERICA; PERITONEUM CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SMALL INTESTINE CANCER; SOFT TISSUE CANCER; STATISTICAL ANALYSIS; THYROID CANCER; UNITED STATES; VULVA CANCER;

EID: 0035815923     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.11.824     Document Type: Article

References (107)

1. Cancer incidence and mortality, 1973-1995: A report card for the U.S.
2. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
3. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
4. Evaluating the incidence-mortality ratios in estimating completeness of cancer registration
5. Conclusions of the work group for high quality criteria for data use
6. Permutation tests for joinpoint regression with applications to cancer rates
7. The changing epidemiology of esophageal cancer
8. Breast Cancer Surveillance Consortium: A national mammography screening and outcomes database
9. Recent trends in U.S. breast cancer incidence, survival, and mortality rates
10. Projected changes in breast cancer incidence due to the trend toward delayed childbearing
11. Breast cancer epidemiology: Summary and future directions
12. Breast cancer: Cause and prevention
13. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
14. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer
15. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
16. Waist circumference, waist: Hip ratio, and risk of breast cancer in the Nurses' health study
17. Dual effects of weight and weight gain on breast cancer risk
18. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit
19. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study
20. Tamoxifen for early breast cancer: An overview of the randomised trials
21. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
22. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
23. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
24. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy
25. Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality
26. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
27. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States
28. Cancer surveillance series: Interpreting trends in prostate cancer - Part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality
29. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of radiation therapy oncology group protocol 85-31
30. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
31. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long-term results of a prospective randomized study
32. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study
33. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking
34. Smoking prevalence and lung cancer death rates
35. Cigarette smoking behavior in the United States
36. Trends in screening for colorectal cancer - United States, 1997 and 1999
37. Incidence of colorectal carcinoma in the U.S.: An update of trends by gender, race, age, subsite, and stage, 1975-1994
38. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort
39. Sex differences in subsite incidence of large-bowel cancer
40. Rightward shift of colon cancer. A feature of the aging gut
41. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
42. Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995
43. Non-Hodgkin's lymphomas
44. Epidemiology of liver cancer in Europe
45. Liver cancer
46. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
47. The use of biomarkers to study pathogenesis and mechanisms of cancer: Oesophagus and skin cancer as models
48. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia
49. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia
50. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
51. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
52. Cancer statistics, 2001
53. The spread of the obesity epidemic in the United States, 1991-1998
54. Melanoma and sun exposure: An overview of published studies
55. Sunlight and cancer
56. Cancer surveillance series: Recent trends in cutaneous melanoma incidence among whites in the United States
57. The leukemias
58. The contribution of benzene to smoking-induced leukemia
59. Human herpes virus-6 seroprevalence and leukaemias: A case-control study
60. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen
61. Soft tissue sarcoma and occupational exposures
62. Exposure to dioxins as a risk factor for soft tissue sarcoma: A population-based case-control study
63. Cancer in phenoxy herbicide manufacturing workers in Denmark, 1947-87 - An update
64. Neoplasms of the small intestine, vermiform appendix, and peritoneum
65. Cancers of the small intestine
66. Thyroid cancer
67. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females
68. Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study
69. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987
70. Thyroid cancer incidence in Asian migrants to the United States and their descendants
71. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption
72. Reproductive factors and risk of papillary thyroid cancer in women
73. Cancers of the vulva and vagina
74. In situ and invasive vulvar cancer incidence trends (1973 to 1987)
75. The peritoneum, mesenteries and omenta: Normal anatomy and pathological processes
76. Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: Diagnosis with CT
77. Ovarian cancer
78. The mistaken diagnosis of carcinoma of the ovary
79. Problems in the histological typing of ovarian cancer
80. The differential diagnosis of primary peritoneal papillary tumors
81. The 1990 post-enumeration survey: Operations and results
82. Reducing tobacco use: A report of the Surgeon General
83. A clinical practice guideline for treating tobacco use and dependence: A U.S
84. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today
85. Melanoma prevention: Is it possible to change a population's behavior in the sun?
86. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: The effect of hepatitis B mass immunization
87. Elimination of new chronic hepatitis B virus infections: Result of the Alaska immunization program
88. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
89. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
90. Prevention of hepatitis B virus transmission by vaccination. An economic analysis of current recommendations
91. Estimating future hepatitis C morbidity, mortality, and costs in the United States
92. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
93. Cancer surveillance in the U.S.: Can we have a national system?
94. The surveillance, Epidemiology and end results program: A national resource
95. SEER doubles coverage by adding registries for four states